MAKO Documents déposés auprès de la SEC - Mako Surgical Corp.- Rapport annuel, procuration, prospectus

Statistiques de base

CIK

1411861

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Mako Surgical Corp.

SEC Filings (Chronological Order)

Cette page fournit une liste complète et chronologique des documents déposés auprès de la SEC, à l'exclusion des documents relatifs à la participation que nous fournissons ailleurs.

February 14, 2014	SC 13D/A	MAKO / Mako Surgical Corp. / Skyline Venture Partners V LP - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
December 27, 2013	15-12B	- 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-33966 MAKO Surgical Corp. (Exact name of Registrant as specified in its c
December 20, 2013	EX-99.2	PIPELINE ORTHOPEDICS, LLC (a wholly owned subsidiary of Pipeline Biomedical Holdings, Inc.) FINANCIAL STATEMENTS DECEMBER 31, 2012 and 2011 Exhibit 99.2 Pipeline Orthopedics, LLC Financial Statements December 31, 2012 and 2011 PIPELINE ORTHOPEDICS, LLC (a wholly owned subsidiary of Pipeline Biomedical Holdings, Inc.) FINANCIAL STATEMENTS DECEMBER 31, 2012 and 2011 PIPELINE ORTHOPEDICS, LLC (a wholly owned subsidiary of Pipeline Biomedical Holdings, Inc.) Contents Page Financial Statements Independent auditors’ report 1 Balance sheets
December 20, 2013	EX-99.1	PIPELINE ORTHOPEDICS, LLC (a wholly owned subsidiary of Pipeline Biomedical Holdings, Inc.) FINANCIAL STATEMENTS SEPTEMBER 30, 2013 and 2012 Exhibit 99.1 Pipeline Orthopedics, LLC Financial Statements September 30, 2013 and 2012 PIPELINE ORTHOPEDICS, LLC (a wholly owned subsidiary of Pipeline Biomedical Holdings, Inc.) FINANCIAL STATEMENTS SEPTEMBER 30, 2013 and 2012 PIPELINE ORTHOPEDICS, LLC (a wholly owned subsidiary of Pipeline Biomedical Holdings, Inc.) Contents Page Financial Statements Independent Accountants’ Review Report 1 Bal
December 20, 2013	8-K/A	Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A Amendment No.
December 20, 2013	EX-99.3	MAKO SURGICAL CORP. AND PIPELINE ORTHOPEDICS, LLC UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 MAKO SURGICAL CORP. AND PIPELINE ORTHOPEDICS, LLC UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On October 1, 2013, the MAKO Surgical Corp. (the “Company” or “MAKO”) entered into an Asset Purchase Agreement with Pipeline Biomedical Holdings, Inc. (the “Pipeline Parent”) and on October 8, 2013, pursuant to the terms of the Asset Purchase Agreement, the Company completed
December 17, 2013	POS AM	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	EX-3.1	Certificate of Incorporation FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION MAKO SURGICAL CORP. EX-3.1 2 mako135166ex3-1.htm FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Exhibit 3.1 Certificate of Incorporation FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MAKO SURGICAL CORP. FIRST: The name of the Corporation is MAKO Surgical Corp. (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, Wi
December 17, 2013	EX-3.2	SIXTH AMENDED AND RESTATED BY-LAWS MAKO SURGICAL Corp. A Delaware Corporation Effective December 17, 2013 TABLE OF CONTENTS Exhibit 3.2 SIXTH AMENDED AND RESTATED BY-LAWS OF MAKO SURGICAL Corp. A Delaware Corporation Effective December 17, 2013 TABLE OF CONTENTS Page ARTICLE I OFFICES 1 Section 1.1 Registered Office 1 Section 1.2 Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 2.1 Place of Meetings 1 Section 2.2 Annual Meetings 1 Section 2.3 Special Meetings 2 Section 2.4 Notice 2 Section 2.5 Adjournments
December 17, 2013	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K 1 mako1351668k.htm FORM 8-K DATED DECEMBER 17, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2013 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State
December 17, 2013	S-8 POS	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	S-8 POS	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	S-8 POS	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	S-8 POS	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	POS AM	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	POS AM	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	S-8 POS	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	POS AM	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	POS AM	- POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-3 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	S-8 POS	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 17, 2013	S-8 POS	- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on December 17, 2013 Registration No.
December 13, 2013	EX-99.1	MAKO SURGICAL CORP. STOCKHOLDERS APPROVE MERGER WITH STRYKER CORPORATION EXHIBIT 99.1 MAKO SURGICAL CORP. STOCKHOLDERS APPROVE MERGER WITH STRYKER CORPORATION FT. LAUDERDALE, Fla., December 13, 2013 – MAKO Surgical Corp. (Nasdaq: MAKO) (“MAKO”) announced that MAKO stockholders voted at a special meeting of stockholders held today to approve the adoption of the Agreement and Plan of Merger (the “Merger Agreement”) providing for the merger of MAKO with and into a wholly
December 13, 2013	8-K	Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2013 MAKO Surgical Corp.
November 27, 2013	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2013 MAKO Surgical Corp.
November 27, 2013	DEFA14A	- FORM 8-K DEFA14A 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2013 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or other jurisdiction of
November 13, 2013	DEFM14A	- DEFINITIVE PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi
November 7, 2013	PRER14A	- PRELIMINARY PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi
November 6, 2013	10-Q	Quarterly Report - FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2013 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-339
November 5, 2013	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2013 EX-99.1 2 mako134583ex99-1.htm PRESS RELEASE ISSUED ON NOVEMBER 5, 2013 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2013 FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — November 5, 2013 — MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and pro
November 5, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 mako1345838k.htm FORM 8-K DATED NOVEMBER 5, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2013 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State o
October 16, 2013	PREM14A	- PRELIMINARY PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi
October 8, 2013	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events - FORM 8-K DATED OCTOBER 8, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2013 MAKO Surgical Corp.
October 8, 2013	EX-99.1	MAKO SURGICAL CORP. ANNOUNCES COMPLETION OF THE ACQUISITION OF ASSETS OF PIPELINE BIOMEDICAL HOLDINGS EX-99.1 2 mako134187ex99-1.htm PRESS RELEASE DATED OCTOBER 8, 2013 Exhibit 99.1 MAKO SURGICAL CORP. ANNOUNCES COMPLETION OF THE ACQUISITION OF ASSETS OF PIPELINE BIOMEDICAL HOLDINGS FT. LAUDERDALE, Fla., Oct. 8, 2013 – MAKO Surgical Corp. (Nasdaq:MAKO) today announced that it has completed the acquisition of Pipeline Biomedical Holdings, Inc.’s business dedicated to the design, development, manufa
October 2, 2013	EX-2.1	ASSET PURCHASE AGREEMENT by and between PIPELINE BIOMEDICAL HOLDINGS, INC. (“Seller”) MAKO SURGICAL CORP. (“Buyer”) Dated: October 1, 2013 Exhibit 2.1 Execution Copy ASSET PURCHASE AGREEMENT by and between PIPELINE BIOMEDICAL HOLDINGS, INC. (“Seller”) and MAKO SURGICAL CORP. (“Buyer”) Dated: October 1, 2013 TABLE OF CONTENTS Page 1. PURCHASE AND SALE OF ASSETS 1 (a) Purchased Assets 1 (b) Excluded Assets 3 2. ASSUMPTION OF LIABILITIES 5 (a) Assumed Liabilities 5 (b) Excluded Liabilities 5 3. PURCHASE PRICE; PAYMENT 6 (a) Purchase Pri
October 2, 2013	EX-99.1	MAKO SURGICAL CORP. ANNOUNCES AGREEMENT TO ACQUIRE ASSETS OF PIPELINE BIOMEDICAL HOLDINGS Exhibit 99.1 MAKO SURGICAL CORP. ANNOUNCES AGREEMENT TO ACQUIRE ASSETS OF PIPELINE BIOMEDICAL HOLDINGS FT. LAUDERDALE, Fla., Oct. 2, 2013 – MAKO Surgical Corp. (Nasdaq:MAKO) today announced that it has entered into an agreement with Pipeline Biomedical Holdings, Inc. to acquire substantially all of Pipeline’s business dedicated to the design, development, manufacture and commercialization of ortho
October 2, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events - FORM 8-K DATED OCTOBER 1, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2013 MAKO Surgical Corp.
September 27, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 mako1340418k.htm FORM 8-K DATED SEPTEMBER 25, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2013 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Sta
September 27, 2013	EX-2.1	AGREEMENT AND PLAN OF MERGER by and among Stryker Corporation, Lauderdale Merger Corporation MAKO Surgical Corp. September 25, 2013 EXHIBIT 2.1 Execution Copy AGREEMENT AND PLAN OF MERGER by and among Stryker Corporation, Lauderdale Merger Corporation and MAKO Surgical Corp. Dated September 25, 2013 ARTICLE I MERGER AND CONVERSION OF SHARES Section 1.1 The Merger 1 Section 1.2 Effective Time 2 Section 1.3 Closing 2 Section 1.4 Directors and Officers of the Surviving Corporation 2 Section 1.5 Subsequent Actions 2 ARTICLE II CON
September 27, 2013	DEFA14A	- FORM 8-K DATED SEPTEMBER 25, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2013 MAKO Surgical Corp.
September 27, 2013	EX-2.1	AGREEMENT AND PLAN OF MERGER by and among Stryker Corporation, Lauderdale Merger Corporation MAKO Surgical Corp. September 25, 2013 EXHIBIT 2.1 Execution Copy AGREEMENT AND PLAN OF MERGER by and among Stryker Corporation, Lauderdale Merger Corporation and MAKO Surgical Corp. Dated September 25, 2013 ARTICLE I MERGER AND CONVERSION OF SHARES Section 1.1 The Merger 1 Section 1.2 Effective Time 2 Section 1.3 Closing 2 Section 1.4 Directors and Officers of the Surviving Corporation 2 Section 1.5 Subsequent Actions 2 ARTICLE II CON
September 25, 2013	8-K	Financial Statements and Exhibits, Other Events - MAKO SURGICAL FORM 8-K 09-25-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2013 MAKO Surgical Corp.
September 25, 2013	EX-99.1	MAKO SURGICAL CORP. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR $30 PER SHARE IN CASH EX-99.1 2 ex99-1.htm PRESS RELEASE Exhibit 99.1 [Mi MAKO SURGICAL CORP. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR $30 PER SHARE IN CASH FT. LAUDERDALE, Fla., Sept. 25, 2013 – MAKO Surgical Corp. (Nasdaq:MAKO) today announced a definitive agreement with Stryker Corporation (NYSE:SYK), by which Stryker will acquire all of the outstanding shares of MAKO for $30.00 per s
September 25, 2013	EX-99.1	MAKO SURGICAL CORP. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR $30 PER SHARE IN CASH Exhibit 99.1 [Mi MAKO SURGICAL CORP. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR $30 PER SHARE IN CASH FT. LAUDERDALE, Fla., Sept. 25, 2013 – MAKO Surgical Corp. (Nasdaq:MAKO) today announced a definitive agreement with Stryker Corporation (NYSE:SYK), by which Stryker will acquire all of the outstanding shares of MAKO for $30.00 per share in cash, for an aggregate purc
September 25, 2013	DEFA14A	- MAKO SURGICAL FORM 8-K 09-25-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2013 MAKO Surgical Corp.
August 1, 2013	10-Q	UNITED STATES Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 MA
July 30, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2013 MAKO Surgical Corp.
July 30, 2013	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2013 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2013 Second Quarter 2013 Highlights Second quarter revenue totaled $28.2 million, a 19% increase over the same period in 2012 Ten RIO® systems sold in the second quarter, of which eight were sold to domestic customers A total of fifteen RIO systems sold worldwide in the first six months of 2013, increasing worldwide
July 8, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2013 MAKO Surgical Corp.
July 8, 2013	EX-99.1	MAKO Surgical Corp. Announces Additions to Board of Directors Exhibit 99.1 MAKO Surgical Corp. Announces Additions to Board of Directors FORT LAUDERDALE, Fla., July 8, 2013 (GlobeNewswire) - MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, re
June 4, 2013	EX-99.1	MAKO Surgical Corp. Announces Addition of Senior Executive to Management Team EX-99.1 4 mako132589ex99-1.htm PRESS RELEASE DATED JUNE 3, 2013 Exhibit 99.1 MAKO Surgical Corp. Announces Addition of Senior Executive to Management Team FORT LAUDERDALE, FL—(GLOBENEWSWIRE)—June 3, 2013 —MAKO Surgical Corp. (NASDAQ: MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications and proprietary RE
June 4, 2013	EX-10.3	IVAN DELEVIC FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT EX-10.3 3 mako132589ex10-3.htm FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT Exhibit 10.3 IVAN DELEVIC FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of May 31, 2013 (the “Effective Date”), by and between MAKO Surgical Corp., a Delaware corporation (the “Company”),
June 4, 2013	EX-10.1	EMPLOYMENT AGREEMENT Exhibit 10.1 CONFIDENTIAL EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of May 31, 2013 (the “Effective Date”), by and between Ian Dawson (“Employee”) and MAKO Surgical Corp. (“Company”). 1. Employment On the terms and conditions set forth in this Agreement, the Company hereby employs the Employee as its Senior Vice President of Marketing for a one (1) year peri
June 4, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders - FORM 8-K DATED MAY 31, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2013 MAKO Surgical Corp.
May 8, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2013 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 M
May 7, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2013 MAKO Surgical Corp.
May 7, 2013	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the First Quarter 2013 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the First Quarter 2013 First Quarter 2013 Highlights First quarter revenue totaled $24.8 million, a 26% increase over the same period in 2012 Five RIO® systems sold in the first quarter, increasing worldwide commercial installed base to 161 RIO systems and domestic commercial installed base to 156 RIO systems 2,988 MAKOplasty® procedur
April 26, 2013	DEF 14A	- DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14
March 21, 2013	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits 8-K 1 mako1313228k.htm FORM 8-K DATED MARCH 15, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2013 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or ot
March 21, 2013	EX-3.1	FIFTH AMENDED AND RESTATED MAKO SURGICAL CORP. Exhibit 3.1 FIFTH AMENDED AND RESTATED BYLAWS OF MAKO SURGICAL CORP. 1. OFFICES 1.1. Registered Office The registered office of the Corporation shall be in Wilmington, Delaware, and the registered agent in charge thereof shall be Corporation Service Company. 1.2. Other Offices The Corporation may also have offices at such other places, both within and without the State of Delaware, as the Board of
March 18, 2013	POS AM	- POS AM Registration No. 333-181277 As filed with the Securities and Exchange Commission on March 18, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 3 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 20-1901148 (State or other jurisdiction of (I.
February 28, 2013	S-8	- FORM S-8 As filed with the United States Securities and Exchange Commission on February 28, 2013 Registration No.
February 28, 2013	POS AM	- POS AM Registration No. 333-181277 As filed with the Securities and Exchange Commission on February 28, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 2 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 20-1901148 (State or other jurisdiction of
February 28, 2013	10-K	UNITED STATES Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 Commission file number: 001-33966 MAKO SURGICAL CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-1901148 (State or Other Jurisdiction of Incorpor
February 26, 2013	EX-10.3	MAKO Surgical Corp. 2013 SVP OF SALES CASH BONUS PLAN Exhibit 10.3 MAKO Surgical Corp. 2013 SVP OF SALES CASH BONUS PLAN Purpose of the Plan: The MAKO Surgical Corp. 2013 SVP of Sales Cash Bonus Plan is designed to attract, retain and motivate its Senior Vice President of Sales by providing meaningful annual cash incentives. Capitalized terms set forth herein are defined in the “Definitions” section below. Any Participant under this Plan are not elig
February 26, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2013 MAKO Surgical Corp.
February 26, 2013	EX-99.1	Three Months Ended December 31, EX-99.1 5 mako130813ex99-1.htm PRESS RELEASE ISSUED ON FEBRUARY 26, 2013 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Fourth Quarter and Full Year 2012 Fourth Quarter and Full Year 2012 Highlights Fourth quarter revenue totaled $30.2 million Full year 2012 revenue totaled $102.7 million, a 22% increase over 2011 Fifteen RIO® systems sold in the fourth quarter, of which thirte
February 26, 2013	EX-10.1	EMPLOYMENT AGREEMENT Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of February 21, 2013 (the “Effective Date”), by and between Christopher Marrus (“Employee”) and MAKO Surgical Corp. (“Company”). 1. Employment On the terms and conditions set forth in this Agreement, the Company hereby employs the Employee as its Senior Vice President of Sales for a one (1) year period c
February 26, 2013	EX-10.2	MAKO Surgical Corp. 2013 LEADERSHIP CASH BONUS PLAN EX-10.2 3 mako130813ex10-2.htm 2013 LEADERSHIP CASH BONUS PLAN Exhibit 10.2 MAKO Surgical Corp. 2013 LEADERSHIP CASH BONUS PLAN Purpose of the Plan: The MAKO Surgical Corp. 2013 Leadership Cash Bonus Plan is designed to attract, retain and motivate management-level employees by providing meaningful annual cash incentives. Capitalized terms set forth herein are defined in the “Definitions” section
February 26, 2013	EX-99.2	MAKO Surgical Corp. Announces Appointment of Christopher R. Marrus as Senior Vice President of Sales Exhibit 99.2 MAKO Surgical Corp. Announces Appointment of Christopher R. Marrus as Senior Vice President of Sales FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — February 21, 2013 —MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together e
February 14, 2013	POSASR	- POSASR Table of Contents Registration No. 333-181277 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 20-1901148 (I.R.S. Employer Identifi
January 7, 2013	EX-99.1	MAKO Surgical Corp. Reports Selected Operating Results for the Fourth Quarter and Full Year 2012 Exhibit 99.1 MAKO Surgical Corp. Reports Selected Operating Results for the Fourth Quarter and Full Year 2012 Fourth Quarter 2012 and Full Year Highlights Fifteen RIO® systems sold in the quarter, of which thirteen were sold to domestic customers Total of 45 RIO systems sold worldwide in 2012, increasing worldwide commercial installed base to 156 RIO systems and domestic commercial installed base
January 7, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2013 MAKO Surgical Corp.
December 13, 2012	CORRESP	- CORRESP 1 filename1.htm 2555 Davie Road • Ft. Lauderdale, FL 33317 Phone 954.927.2044 • Fax 954.927.0446 www.makosurgical.com December 13, 2012 BY EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Kevin L. Vaughn, Accounting Branch Chief Lynn Dicker, Reviewing Accountant Tara Harkins, Sta
December 10, 2012	SC 13G/A	MAKO / Mako Surgical Corp. / GILDER GAGNON HOWE & CO LLC - DECEMBER 10, 2012 Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No.3)* MAKO Surgical Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 560879108 (CUSIP Number) November 30, 2012 (Date of Event which Requires Filing of th
November 16, 2012	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2012 MAKO Surgical corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or other jurisdiction of incorporation) (Commission F
November 15, 2012	EX-1.1	3,042,000 Shares MAKO Surgical Corp. Common Stock PURCHASE AGREEMENT EX-1.1 2 mako12480ex1-1.htm PURCHASE AGREEMENT EXHIBIT 1.1 3,042,000 Shares MAKO Surgical Corp. Common Stock PURCHASE AGREEMENT November 14, 2012 PIPER JAFFRAY & CO. 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: MAKO Surgical Corp., a Delaware corporation (the “Company”), proposes to sell to Piper Jaffray & Co. (the “Underwriter”) an aggregate of 3,042,000 shares (the “Firm
November 15, 2012	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K DATED NOVEMBER 14, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2012 MAKO SURGICAL CORP. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or other jurisdiction of incorporation) (Commission F
November 14, 2012	424B5	CALCULATION OF REGISTRATION FEE Filed Pursuant to Rule 424(b)(5) Registration No. 333-181277 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered(1)(2) Proposed maximum offering price per share(3) Maximum aggregate offering price(2)(3) Amount of registration fee Common Stock, $.001 par value 3,498,300 $13.80 $48,276,540 $6,584.92 (1) The securities registered herein are offer
November 14, 2012	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2012 MAKO Surgical corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or other jurisdiction of incorporation) (Commission F
November 14, 2012	FWP	Common Stock Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated November 14, 2012 Supplementing the Preliminary Prospectus Supplement dated November 13, 2012 Relating to Registration Statement No.
November 14, 2012	424B5	CALCULATION OF REGISTRATION FEE 424B5 1 mako124748424b5.htm 424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-181277 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered(1) Proposed maximum offering price per share(2) Maximum aggregate offering price(2) Amount of registration fee Common Stock, $.001 par value 490,471 $13.80 $6,768,499.80 $923.22 (1) The securities r
November 13, 2012	424B5	SUBJECT TO COMPLETION PRELIMINARY PROSPECTUS SUPPLEMENT, DATED NOVEMBER 13, 2012 Table of Contents The information in this preliminary prospectus supplement is not complete and may be changed.
November 8, 2012	10-Q	UNITED STATES 10-Q 1 mako12468110q.htm FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2012 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A
November 8, 2012	EX-10.3	MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN NON-QUALIFIED STOCK OPTION AGREEMENT Exhibit 10.3 Option No.: MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN NON-QUALIFIED STOCK OPTION AGREEMENT MAKO Surgical Corp., a Delaware corporation (the “Company”), hereby grants an option to purchase shares of its common stock, $.001 par value, (the “Stock”) to the optionee named below. The terms and conditions of the option are set forth in this cover sheet and in the attachment (together,
November 8, 2012	EX-10.2	MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT Exhibit 10.2 Option No.: MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT MAKO Surgical Corp., a Delaware corporation (the “Company”), hereby grants an option to purchase shares of its common stock, $.001 par value, (the “Stock”) to the optionee named below. The terms and conditions of the option are set forth in this cover sheet and in the attachment (together, the
November 8, 2012	EX-4.1	PIPELINE BIOMEDICAL HOLDINGS, INC. COMMON STOCK SUBSCRIPTION AGREEMENT MAKO SURGICAL CORP. Exhibit 4.1 PIPELINE BIOMEDICAL HOLDINGS, INC. COMMON STOCK SUBSCRIPTION AGREEMENT OF MAKO SURGICAL CORP. All capitalized terms not defined herein shall have the meanings ascribed to such terms in Annex A attached hereto. MAKO Surgical Corp., a Delaware corporation (“Subscriber”) hereby agrees as follows: 1. Subscription and Credit; Consideration. (a) Subscriber hereby irrevocably subscribes (“Sub
November 7, 2012	8-K	Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2012 MAKO Surgical Corp.
November 7, 2012	EX-4.2	REGISTRATION RIGHTS AGREEMENT Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the “Registration Rights Agreement”) is dated as of November 7, 2012, and is entered into by and between MAKO Surgical Corp., a Delaware corporation having its principal office at 2555 Davie Road, Fort Lauderdale, Florida 33317 (the “Company”), and Pipeline Biomedical Holdings, Inc. (successor by merger to Pipeline Biome
November 7, 2012	EX-4.1	PIPELINE BIOMEDICAL HOLDINGS, INC. COMMON STOCK SUBSCRIPTION AGREEMENT MAKO SURGICAL CORP. EX-4.1 2 mako124677ex4-1.htm SUBSCRIPTION AGREEMENT DATED NOVEMBER 7, 2012 Exhibit 4.1 PIPELINE BIOMEDICAL HOLDINGS, INC. COMMON STOCK SUBSCRIPTION AGREEMENT OF MAKO SURGICAL CORP. All capitalized terms not defined herein shall have the meanings ascribed to such terms in Annex A attached hereto. MAKO Surgical Corp., a Delaware corporation (“Subscriber”) hereby agrees as follows: 1. Subscription an
November 7, 2012	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2012 EX-99.1 4 mako124677ex99-1.htm PRESS RELEASE DATED NOVEMBER 7, 2012 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2012 Third Quarter 2012 Highlights Third quarter revenue totaled $29.2 million, a 46% increase over the same period in 2011 Fifteen RIO® systems sold in the third quarter, increasing worldwide commercial installed base to 141 RIO systems and domestic
October 3, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED OCTOBER 1, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2012 MAKO Surgical Corp.
October 3, 2012	EX-10.1	2012 MAKOplasty Bonus Plan for Ivan Delevic (this “Plan”) Effective Date: October 1, 2012 Termination Date: December 31, 2012 EX-10.1 2 mako12412810-1.htm 2012 MAKOPLASTY BONUS PLAN FOR IVAN DELEVIC Exhibit 10.1 2012 MAKOplasty Bonus Plan for Ivan Delevic (this “Plan”) Effective Date: October 1, 2012 Termination Date: December 31, 2012 1. Overview a. A Volume Bonus (as defined below), in the form of cash, shall be payable to Ivan Delevic (the “Executive”) based on achievement of annual sales metrics of procedures as set
August 7, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2012 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 MA
August 1, 2012	EX-10.2	INDEPENDENT CONTRACTOR CONSULTING SERVICES AGREEMENT Exhibit 10.2 INDEPENDENT CONTRACTOR CONSULTING SERVICES AGREEMENT This Independent Contractor Consulting Services Agreement (this “Agreement”) is made and entered into, to be effective as of the date entered below, by and between MAKO Surgical Corp. (“MAKO”), a corporation formed under the laws of the State of Delaware with a principal place of business at 2555 Davie Road, Fort Lauderdale, Florida
August 1, 2012	EX-10.3	IVAN DELEVIC AMENDED AND RESTATED EMPLOYMENT AGREEMENT Exhibit 10.3 IVAN DELEVIC AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made effective as of July 30, 2012 (the “Effective Date”), by and between MAKO Surgical Corp., a Delaware corporation (the “Company”), and Ivan Delevic (the “Executive”). WHEREAS, the Executive is and has been employed by the Company and is currently the Company’
August 1, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED JULY 26, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2012 MAKO Surgical Corp.
August 1, 2012	EX-10.1	July 24, 2012 EX-10.1 2 mako123163ex10-1.htm LETTER AGREEMENT BETWEEN MAKO SURGICAL CORP. AND STEVEN J. NUNES Exhibit 10.1 July 24, 2012 Steven J. Nunes 2605 SE 2nd Court Pompano Beach, FL 33062 Dear Steven: This letter agreement confirms your resignation as an employee of MAKO Surgical Corp. (“MAKO”) as of July 17, 2012 (the “Separation Date”). The purpose of this letter agreement is to confirm the agreement b
August 1, 2012	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2012 EX-99.1 5 mako123163ex99-1.htm PRESS RELEASE ISSUED AUGUST 1, 2012 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2012 Second Quarter 2012 Highlights Second quarter revenue totaled $23.7 million, a 27% increase over the same period in 2011 Nine RIO® systems sold in the second quarter, increasing worldwide commercial installed base to 126 RIO systems and domestic
July 23, 2012	EX-99.1	MAKO Surgical Corp. Announces Management Changes EX-99.1 2 mako122976ex99-1.htm PRESS RELEASE ISSUED JULY 18, 2012 Exhibit 99.1 MAKO Surgical Corp. Announces Management Changes FORT LAUDERDALE, FL—(GLOBENEWSWIRE)—July 18, 2012 —MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that toge
July 23, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED JULY 17, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2012 MAKO Surgical Corp.
July 9, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 mako1228658k.htm FORM 8-K DATED JULY 9, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2012 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or other jurisdiction of incor
July 9, 2012	EX-99.1	MAKO Surgical Corp. Reports Selected Operating Results for the Second Quarter 2012 Exhibit 99.1 MAKO Surgical Corp. Reports Selected Operating Results for the Second Quarter 2012 Second Quarter 2012 Highlights Nine RIO® systems sold in the second quarter, increasing worldwide commercial installed base to 126 RIO systems and domestic commercial installed base to 123 RIO systems A total of fifteen RIO systems sold worldwide in the first six months of 2012 2,590 MAKOplasty® procedu
July 3, 2012	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2012 MAKO Surgical corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or other jurisdiction of incorporation) (Commission File
July 3, 2012	EX-10.1	FIRST AMENDMENT TO FACILITY AGREEMENT EX-10.1 3 mako122804ex10-1.htm FIRST AMENDMENT TO FACILITY AGREEMENT Exhibit 10.1 FIRST AMENDMENT TO FACILITY AGREEMENT THIS FIRST AMENDMENT TO FACILITY AGREEMENT (this “Amendment”), effective as of June 28, 2012, amends and restates Exhibit D-2 to that certain Facility Agreement (the “Facility Agreement”) between MAKO Surgical Corp., a Delaware corporation (the “Borrower”), and Deerfield Private
July 3, 2012	EX-4.1	FIRST AMENDMENT TO WARRANT EX-4.1 2 mako122804ex4-1.htm FIRST AMENDMENT TO WARRANT Exhibit 4.1 FIRST AMENDMENT TO WARRANT THIS FIRST AMENDMENT TO WARRANT (this “Amendment”), effective as of June 28, 2012, amends certain terms of that certain warrant number (the “Warrant”) issued by MAKO Surgical Corp., a Delaware corporation (the “Company”), to (the “Holder”) on May 7, 2012, relating to the right of the Holder to purchase f
June 11, 2012	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2012 MAKO Surgical Corp.
June 5, 2012	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2012 MAKO Surgical Corp.
June 5, 2012	424B5	CALCULATION OF REGISTRATION FEE Filed Pursuant to Rule 424(b)(5) Registration No. 333-181277 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered(1) Proposed maximum offering price per share(2) Maximum aggregate offering price(2) Amount of registration fee Common Stock, $.001 par value 275,000 $21.43 $5,893,250 $676.00 (1) The securities registered herein are offered pursuant
May 9, 2012	S-3ASR	- S-3ASR Table of Contents Registration No. 333- As filed with the Securities and Exchange Commission on May 9, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 20-1901148 (State or other jurisdiction of incorporation or organizatio
May 9, 2012	EX-12	MAKO SURGICAL CORP. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDEND AND ACCRETION REQUIREMENTS Exhibit 12 MAKO SURGICAL CORP. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDEND AND ACCRETION REQUIREMENTS Three Months Ended March 31, 2012 (in thousands) Years Ended December 31, Earnings (loss): 2011 2010 2009 2008 2007 Pretax loss from continuing operations $ (11,705 ) $ (36,038 ) $ (38,619 ) $ (33,967 ) $ (37,082 )
May 7, 2012	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the First Quarter 2012 and $50 Million Debt Funding Commitment Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the First Quarter 2012 and $50 Million Debt Funding Commitment First Quarter 2012 Highlights and Debt Funding Commitment First quarter revenue totaled $19.6 million, a 51% increase over the same period in 2011 Six RIO® systems sold in the first quarter, increasing worldwide commercial installed base to 118 RIO systems and domestic comm
May 7, 2012	10-Q	UNITED STATES 10-Q 1 mako12167710q.htm FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2012 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19
May 7, 2012	EX-10.3	SECURITY AGREEMENT Exhibit 10.3 SECURITY AGREEMENT This Security Agreement (this “Agreement”), dated as of May , 2012, is entered into between MAKO Surgical Corp. ("Mako") in favor of the parties identified as Lenders on the signature page of this Agreement (the “Secured Party”). W I T N E S S E T H: WHEREAS, Mako has issued to the Lenders a promissory note dated May , 2012 issued pursuant a Facility Agreement dated
May 7, 2012	EX-4.1	Warrant to Purchase Common Stock of MAKO Surgical Corp. EX-4.1 2 mako122034ex4-1.htm FORM OF WARRANT Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (I) A REGISTRATION STATEMENT UNDER THE SECURITI
May 7, 2012	EX-10.2	REGISTRATION RIGHTS AGREEMENT EX-10.2 4 mako122034ex10-2.htm REGISTRATION RIGHTS AGREEMENT Exhibit 10.2 Execution Copy REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 7, 2012, by and among MAKO Surgical Corp., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (each individually, a “Lender” and together,
May 7, 2012	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2012 MAKO Surgical Corp.
May 7, 2012	EX-10.1	FACILITY AGREEMENT Exhibit 10.1 Execution Version FACILITY AGREEMENT FACILITY AGREEMENT (this “Agreement”), dated as of May 7, 2012, between MAKO Surgical Corp., a Delaware corporation (the “Borrower”), and the lenders set forth on Schedule 1 attached hereto ( the “Lenders” and, together with the Borrower, the “Parties”). W I T N E S S E T H: WHEREAS, the Borrower wishes to borrow from the Lenders fifty million Doll
April 27, 2012	DEF 14A	- DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14
March 8, 2012	EX-10.9	MAKO SURGICAL CORP. EMPLOYEE STOCK PURCHASE PLAN SUBSCRIPTION AGREEMENT Exhibit 10.9 MAKO SURGICAL CORP. EMPLOYEE STOCK PURCHASE PLAN SUBSCRIPTION AGREEMENT New Election Change of Election 1. I, , hereby elect to participate in the MAKO Surgical Corp. (“MAKO”) Employee Stock Purchase Plan (the “Plan”) for the Offering Period commencing , 20, and subscribe to purchase shares of the Company’s Common Stock in accordance with this Subscription Agreement and the Plan. In a
March 8, 2012	S-8	- FORM S-8 S-8 1 mako120986s8.htm FORM S-8 As filed with the United States Securities and Exchange Commission on March 8, 2012 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 20-1901148 (State or Other Jurisdiction o
March 8, 2012	10-K	UNITED STATES 10-K 1 mako12044710k.htm FORM 10-K FOR FISCAL YEAR ENDED DECEMBER 31, 2011 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 Commission file number: 001-33966 MAKO SURGICAL CORP. (Exact Name of Registrant as Specified i
March 6, 2012	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the Fourth Quarter and Full Year 2011 EX-99.1 2 mako120987ex99-1.htm PRESS RELEASE DATED MARCH 6, 2012 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Fourth Quarter and Full Year 2011 Fourth Quarter and Full Year 2011 Highlights Fourth quarter revenue totaled $32.9 million, a 122% increase over the same period in 2010 Full year 2011 revenue totaled $84.5 million, a 91% increase over 2010 Eighteen RIO® systems sold
March 6, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 mako1209878k.htm FORM 8-K DATED MARCH 6, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2012 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or othe
February 27, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED FEBRUARY 23, 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2012 MAKO Surgical Corp.
February 27, 2012	EX-10.1	MAKO Surgical Corp. 2012 LEADERSHIP CASH BONUS PLAN Exhibit 10.1 MAKO Surgical Corp. 2012 LEADERSHIP CASH BONUS PLAN Purpose of the Plan: The MAKO Surgical Corp. 2012 Leadership Cash Bonus Plan is designed to attract, retain and motivate management-level employees by providing meaningful annual cash incentives. Capitalized terms set forth herein are defined in the “Definitions” section below. Participants under this Plan are not eligible for awards
February 14, 2012	SC 13G/A	MAKO / Mako Surgical Corp. / GILDER GAGNON HOWE & CO LLC - SCHEDULE SC 13G AMENDMENT NO. 2 Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2. Under the Securities Exchange Act of 1934 (Amendment No. 2) MAKO Surgical Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 560879108 (CUSIP Number) Decembe
January 31, 2012	EX-10.2	EMPLOYMENT AGREEMENT Exhibit 10.2 EXECUTION VERSION EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of February 3, 2012 (the “Effective Date”), by and between Lawrence T. Gibbons (“Employee”) and MAKO Surgical Corp. (“Company”). 1. Employment On the terms and conditions set forth in this Agreement, the Company hereby employs the Employee as its Senior Vice President of Regulatory Affa
January 31, 2012	EX-10.1	SEVERANCE AGREEMENT AND FULL AND FINAL RELEASE Exhibit 10.1 EXECUTION VERSION SEVERANCE AGREEMENT AND FULL AND FINAL RELEASE This Severance Agreement and Full and Final Release (this “Severance Agreement”), by and between James E. Keller (“Former Employee”) and MAKO Surgical Corp. (“MAKO,” and together with Former Employee, the “Parties”), shall be effective as of February 3, 2012 (the “Effective Date”). RECITALS WHEREAS, MAKO is a medical dev
January 31, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2012 MAKO Surgical Corp.
January 9, 2012	EX-99.1	MAKO Surgical Corp. Reports Selected Operating Results for the Fourth Quarter and Full Year 2011 and Announces 2012 Annual Guidance Exhibit 99.1 MAKO Surgical Corp. Reports Selected Operating Results for the Fourth Quarter and Full Year 2011 and Announces 2012 Annual Guidance Fourth Quarter 2011 and Full Year Highlights Eighteen RIO® systems sold in the quarter, of which sixteen were sold to domestic customers Total of 48 RIO systems sold worldwide in 2011, increasing worldwide commercial installed base to 113 RIO systems and
January 9, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 mako1200778k.htm FORM 8-K DATED JANUARY 9, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2012 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or
November 30, 2011	SC 13D/A	UNITED STATES SC 13D/A 1 a11-307551sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* MAKO SURGICAL CORP. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 560879108 (CUSIP Number) Daniel K. Turner, III 3000 Sand Hill Road Building 1, Suite 260 Menlo Park, CA
November 9, 2011	EX-10.1	SECOND AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.1 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT THIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of November 7, 2011 (the “Effective Date”), by and between Ivan Delevic (“Employee”) and MAKO Surgical Corp. (“Company”). WHEREAS, Employee and Company have entered into that certain Employment Agreement, effective as of April 27, 2009, as amended by that Firs
November 9, 2011	EX-10.3	FIRST AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.3 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of November 7, 2011 (the “Effective Date”), by and between Duncan Moffat (“Employee”) and MAKO Surgical Corp. (“Company”). WHEREAS, Employee and Company have entered into that certain Employment Agreement, effective as of April 28, 2008 (the “Agreement”); and WH
November 9, 2011	EX-10.2	FIRST AMENDMENT TO EMPLOYMENT AGREEMENT Exhbit 10.2 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of November 7, 2011 (the “Effective Date”), by and between Richard Leparmentier (“Employee”) and MAKO Surgical Corp. (“Company”). WHEREAS, Employee and Company have entered into that certain Employment Agreement, effective as of March 29, 2010 (the “Agreement”);
November 9, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2011 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-339
November 9, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2011 MAKO Surgical Corp UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2011 MAKO Surgical Corp.
November 9, 2011	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2011 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2011 Third Quarter and Nine-Month 2011 Highlights Third quarter revenue totaled $20.0 million, a 67% increase over the same period in 2010 Eleven RIO® systems sold in the third quarter, increasing worldwide commercial installed base to 97 RIO systems A total of thirty RIO systems sold worldwide in the first nine month
August 9, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 MA
August 8, 2011	EX-99.1	Three Months Ended June 30, Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2011 Second Quarter and Six-Month 2011 Highlights Second quarter revenue totaled $18.6 million, an 81% increase over the same period in 2010 Twelve RIO® systems sold in the second quarter, including ten domestic commercial sales and two international commercial sales, increasing worldwide commercial installed base to
August 8, 2011	8-K	UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2011 MAKO Surgical Corp.
June 16, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2011 MAKO Surgical Corp. ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2011 MAKO Surgical Corp.
June 10, 2011	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2011 MAKO Surgical Corp.
June 10, 2011	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Amendment No. 1 (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2. Under t SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Amendment No. 1 (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2. Under the Securities Exchange Act of 1934 MAKO Surgical Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 560879108 (CUSIP Number) May 31, 2
May 31, 2011	SC 13D/A	SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
May 5, 2011	10-Q	Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2011 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 M
May 3, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2011 MAKO Surgical Corp. (Ex mako1123538k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2011 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State
May 3, 2011	EX-99.1	Three Months Ended March 31, Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the First Quarter 2011 First Quarter 2011 Highlights First quarter revenue totaled $13.0 million, an 80% increase over the same period in 2010 Seven RIO® systems sold in the quarter, increasing domestic commercial installed base to 74 RIO systems 1,304 MAKOplasty® procedures performed in the quarter, a 78% increase over the same period
April 28, 2011	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEF 14A 1 mako111276s1def14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confident
March 10, 2011	EX-10.6	ARTICLE I Exhibit 10.6 LEASE THIS LEASE is made and is entered into by and between Westport Business Park Associates LLP, a Florida limited liability partnership (the “Landlord”) and MAKO Surgical Corp., a Delaware corporation (the “Tenant” or “You” or “you”). TERMS In consideration of the covenants and agreements herein contained, Landlord does hereby lease to you, and you do take and lease from Landlord t
March 10, 2011	10-K	UNITED STATES Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 Commission file number: 001-33966 MAKO SURGICAL CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-1901148 (State or Other Jurisdiction of Incorpor
March 10, 2011	S-8	As filed with the United States Securities and Exchange Commission on March 10, 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT PURSUANT TO GENERAL INSTRUCTION E TO FORM S-8 PART II SIGNATURES As filed with the United States Securities and Exchange Commission on March 10, 2011 Registration No.
March 10, 2011	SC 13G	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2. Under the Securities Ex SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2. Under the Securities Exchange Act of 1934 MAKO Surgical Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 560879108 (CUSIP Number) February 28, 2011 (Date o
March 1, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2011 MAKO Surgical Corp. ( mako1110458k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2011 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Stat
March 1, 2011	EX-99.1	As Reported (U.S. GAAP) EX-99.1 2 mako111045ex99-1.htm PRESS RELEASE DATED MARCH 1, 2011 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Fourth Quarter and Full Year 2010 Fourth Quarter and Full Year 2010 Highlights Fourth quarter revenue totaled $14.8 million, a 67% increase over the same period in 2009 Thirteen RIO® systems sold in the quarter, increasing domestic commercial installed base to 67 RIO
February 14, 2011	SC 13D/A	SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
February 11, 2011	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 1) MAKO S SC 13G/A 1 dsc13ga.htm SCHEDULE 13G AMENDMENT NO. 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. 1) MAKO Surgical Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 560879108 (CUSIP Number
February 7, 2011	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 MAKO Surgical Corp. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) November SC 13G/A 1 v210291sc13g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 MAKO Surgical Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 560879108 (CUSIP Number) November 8, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul
February 4, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2011 MAKO Surgical Corp mako1105538k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2011 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (S
February 4, 2011	EX-10.2	MAKO Surgical Corp. 2011 LEADERSHIP CASH BONUS PLAN EX-10.2 3 mako110553ex10-2.htm 2011 LEADERSHIP CASH BONUS PLAN Exhibit 10.2 MAKO Surgical Corp. 2011 LEADERSHIP CASH BONUS PLAN Purpose of the Plan: The MAKO Surgical Corp. 2011 Leadership Cash Bonus Plan is designed to attract, retain and motivate management-level employees by providing meaningful annual cash incentives. Capitalized terms set forth herein are defined in the “Definitions” section
February 4, 2011	EX-10.1	MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK AGREEMENT EX-10.1 2 mako110553ex10-1.htm RESTRICTED STOCK AGREEMENT Exhibit 10.1 Grant No.: 8 MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK AGREEMENT MAKO Surgical Corp., a Delaware corporation (the “Company”), effective as of the Grant Date below, grants shares of its common stock, $.001 par value, (the “Stock”) to the Grantee named below, subject to the vesting conditions set forth in t
February 2, 2011	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* UNDER THE SECURITIES EXCHANGE ACT OF 1934 MAKO SURGICAL CORP (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) December UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* UNDER THE SECURITIES EXCHANGE ACT OF 1934 MAKO SURGICAL CORP (Name of Issuer) Common Stock (Title of Class of Securities) 560879108 (CUSIP Number) December 31, 2010 (Date of Event That Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched
January 10, 2011	EX-99.1	MAKO Surgical Corp. Reports Selected Operating Results for the Fourth Quarter 2010 Exhibit 99.1 MAKO Surgical Corp. Reports Selected Operating Results for the Fourth Quarter 2010 Fourth Quarter 2010 and Full Year Highlights Thirteen RIO® systems sold in the quarter, increasing domestic commercial installed base to 67 RIO systems Total of 33 RIO systems sold worldwide in 2010 1,146 MAKOplasty® procedures performed in the quarter, a 104% increase over the same period in 2009 Total
January 10, 2011	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2011 MAKO Surgical Corp mako1101188k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2011 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (S
November 5, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2010 MAKO Surgical co mako1055518k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2010 MAKO Surgical corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148
November 5, 2010	424B5	______________ This investment involves risk. See “Risk Factors” beginning on page S-3 in this prospectus supplement. Filed Pursuant to Rule 424(b)(5) Registration No. 333-169464 PROSPECTUS SUPPLEMENT To Prospectus dated September 28, 2010 5,500,000 Shares MAKO SURGICAL CORP. Common Stock Ÿ MAKO Surgical Corp. is offering 5,500,000 shares. Ÿ Trading symbol: NASDAQ Global Market – MAKO Ÿ The last reported sale price of our common stock on November 3, 2010 was $10.49 per share. This investment involves risk. See “R
November 5, 2010	EX-1.1	1. Registration Statement and Prospectus. The Company has prepared and filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-3 (File No. 333-169464) under the Securities Act of 1933, as amended (the “ Exhibit 1.1 5,500,000 Shares1 MAKO Surgical Corp. Common Stock PURCHASE AGREEMENT November 3, 2010 PIPER JAFFRAY & CO. 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: MAKO Surgical Corp., a Delaware corporation (the “Company”), proposes to sell to Piper Jaffray & Co. (the “Underwriter”) an aggregate of 5,500,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per
November 4, 2010	FWP	MAKO Surgical Corp. 5,500,000 Shares Filed Pursuant To Rule 433 Issuer Free Writing Prospectus dated November 4, 2010 Relating to Registration Statement on Form S-3 Registration No.
November 4, 2010	FWP	MAKO Surgical Corp. 5,500,000 Shares FWP 1 mako105543fwp1.htm FWP Filed Pursuant To Rule 433 Issuer Free Writing Prospectus dated November 4, 2010 Relating to Registration Statement on Form S-3 Registration No. 333-169464 MAKO Surgical Corp. 5,500,000 Shares This free writing prospectus relates only to the securities described in, and should be read together with, the prospectus dated September 28, 2010 (the “Prospectus”) included in
November 3, 2010	10-Q	Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2010 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966
November 2, 2010	EX-99.1	MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2010 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2010 Third Quarter 2010 Highlights Third quarter revenue totaled $12.0 million, a 79% increase over revenue generated in the same period in 2009 Nine RIO® systems sold, increasing domestic commercial installed base to 54 RIO systems Through the third quarter of 2010, a total of 20 RIO systems have been sold worldwide
November 2, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2010 MAKO Surgical Corp mako1054868k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (S
September 17, 2010	S-3	(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amend Registration No. 333- As filed with the Securities and Exchange Commission on September 17, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S‑3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 20-1901148 (I.R.S.
September 17, 2010	EX-4.3	MAKO SURGICAL CORP. FORM OF INDENTURE Dated as of _________________, ____ Debt Securities Exhibit 4.3 MAKO SURGICAL CORP. TO Trustee FORM OF INDENTURE Dated as of , Debt Securities MAKO SURGICAL CORP. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of , ss.310 (a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608, 610 (c) Not Applicable ss.311 (a) 613 (b) 613 ss.312 (a) 701, 702(a) (b) 702(b) (c) 702(c) ss.313 (a) 703(a)
September 17, 2010	EX-12	MAKO SURGICAL CORP. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDEND AND ACCRETION REQUIREMENTS Exhibit 12 MAKO SURGICAL CORP. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDEND AND ACCRETION REQUIREMENTS (in thousands) Six Months Ended June 30, Years Ended December 31, Earnings (loss): 2010 2009 2008 2007 2006 2005 Pretax loss from continuing operations $ (19,885 ) $ (34,023 ) $ (37,082 ) $ (20,658 ) $ (10,617 ) $ (
August 25, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2010 MAKO Surgical Corp. mako1041598k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (St
August 25, 2010	EX-24.1	EX-24.1 Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Menashe R.
August 25, 2010	EX-99.1	MAKO Surgical Corp. Announces Addition to Board of Directors Exhibit 99.1 MAKO Surgical Corp. Announces Addition to Board of Directors FORT LAUDERDALE, FL—(GLOBENEWSWIRE)—August 25, 2010 —MAKO Surgical Corp. (NASDAQ: MAKO), a medical device company that markets both its RIO® robotic arm interactive orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced that Rich
August 13, 2010	CORRESP	August 13, 2010 CORRESP 1 filename1.htm 2555 Davie Road • Ft. Lauderdale, FL 33317 Phone 954.927.2044 • Fax 954.927.0446 www.makosurgical.com August 13, 2010 BY EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Jeff Jaramillo, Branch Chief Julie Sherman, Staff Accountant Re: MAKO Surgical Corp. Form 10-K
August 4, 2010	10-Q	Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:001-33966 MAK
August 3, 2010	EX-99.1	As Reported (U.S. GAAP) Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2010 Second Quarter 2010 Highlights Second quarter revenue totaled $10.3 million, a 151% increase over total revenue generated in the same period in 2009 Seven RIO® systems sold, increasing domestic commercial installed base to 46 RIO systems 793 MAKOplasty® procedures performed, a 122% increase over the same period
August 3, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2010 MAKO Surgical Corp. mako1037718k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Sta
June 17, 2010	SC 13D/A	SECURITIES AND EXCHANGE COMMISSION SC 13D/A 1 a10-120901sc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* MAKO SURGICAL CORP. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 560879108 (CUSIP Number) Daniel K. Turner III 3000 Sand Hill Road Building 1, Suite 260 Menlo Park, CA 94025-7073 (650)
June 14, 2010	EX-24	EX-24 Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Menashe R.
June 14, 2010	EX-24	EX-24 Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Menashe R.
June 14, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2010 MAKO Surgical Corp. ( mako1029688k1.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Sta
May 20, 2010	SC 13D/A	SECURITIES AND EXCHANGE COMMISSION SC 13D/A 1 a10-105151sc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* MAKO SURGICAL CORP. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 560879108 (CUSIP Number) Daniel K. Turner III 3000 Sand Hill Road Building 1, Suite 260 Menlo Park, CA 94025-7073 (650)
May 7, 2010	EX-10.4	FIRST AMENDMENT TO EMPLOYMENT AGREEMENT Exhibit 10.4 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made effective as of April 13, 2010 (the “Effective Date”), by and between Ivan Delevic (“Employee”) and MAKO Surgical Corp. (“Company”). WHEREAS, Employee and Company have entered into that certain Employment Agreement, effective as of April 27, 2010 (the “Agreement”); and WHERE
May 7, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 M
May 7, 2010	EX-10.5	MAKO SURGICAL CORP. EMPLOYEE STOCK PURCHASE PLAN SUBSCRIPTION AGREEMENT EX-10.5 3 mako102277ex10-5.htm FORM OF SUBSCRIPTION AGREEMENT Exhibit 10.5 MAKO SURGICAL CORP. EMPLOYEE STOCK PURCHASE PLAN SUBSCRIPTION AGREEMENT New Election Change of Election 1. I, , hereby elect to participate in the MAKO Surgical Corp. (“MAKO”) Employee Stock Purchase Plan (the “Plan”) for the Offering Period commencing , 20, and subscribe to purchase shares of the Company’s Common Stock in
May 6, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2010 MAKO Surgical Corp. (Ex mako1022838k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State
May 6, 2010	EX-99.1	Three Months Ended March 31, Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the First Quarter 2010 Highlights First quarter revenue totaled $7.2 million, a 94% increase over the same period in 2009 Commercial installed base increased by four systems to 40 RIO® systems 731 MAKOplasty® procedures performed, a 30% sequential increase from fourth quarter 2009 FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — May 6, 2010 —MA
April 28, 2010	DEF 14A	UNITED STATES DEF 14A 1 mako101249s1def14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidenti
April 15, 2010	EX-10.1	MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK AGREEMENT EX-10.1 2 mako101880ex10-1.htm RESTRICTED STOCK AGREEMENT DATED APRIL 13, 2010 Exhibit 10.1 Grant No.: 7 MAKO SURGICAL CORP. 2008 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK AGREEMENT MAKO Surgical Corp., a Delaware corporation (the “Company”), effective as of the Grant Date below, grants shares of its common stock, $.001 par value, (the “Stock”) to the Grantee named below, subject to the vesting cond
April 15, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2010 MAKO Surgical Corp. mako1018808k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Sta
March 29, 2010	EX-10.1	EMPLOYMENT AGREEMENT Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of March 29, 2010 (the “Effective Date”), by and between Richard Leparmentier (“Employee”) and MAKO Surgical Corp. (“Company”). 1. Employment On the terms and conditions set forth in this Agreement, the Company hereby employs the Employee as its Senior Vice President of Engineering for a one (1) year per
March 29, 2010	EX-10.2	FIRST AMENDED AND RESTATED EMPLOYMENT AGREEMENT Exhibit 10.2 EXECUTION VERSION FIRST AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS FIRST AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of March 29, 2010 (the “Effective Date”), by and between Rony Abovitz (“Employee”) and MAKO Surgical Corp. (“Company”). WHEREAS, Employee and Company entered into that certain Employment Agreement, effective as of January 1, 2005 (as
March 29, 2010	EX-99.1	MAKO Surgical Corp. Announces Additions to Senior Management Team Exhibit 99.1 MAKO Surgical Corp. Announces Additions to Senior Management Team FORT LAUDERDALE, FL—(GLOBENEWSWIRE)—March 29, 2010 —MAKO Surgical Corp. (NASDAQ: MAKO), a medical device company that markets both its RIO® robotic arm interactive orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced that
March 29, 2010	EX-24.3_324591	EX-24.3_324591 Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Menashe R.
March 29, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2010 MAKO Surgical Corp. mako1015078k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Sta
March 26, 2010	SC 13D/A	SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
March 24, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2010 MAKO Surgical Corp. mako1014458k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Sta
March 24, 2010	EX-10.1	EMPLOYMENT AGREEMENT Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of March 22, 2010 (the “Effective Date”), by and between James E. Keller (“Employee”) and MAKO Surgical Corp. (“Company”). 1. Employment On the terms and conditions set forth in this Agreement, the Company hereby employs the Employee as its Senior Vice President of Regulatory Affairs and Quality Assuranc
March 24, 2010	EX-24.3_324272	EX-24.3_324272 Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Menashe R.
March 10, 2010	EX-99.1	REGISTRATION RIGHTS AGREEMENT Exhibit 99.1 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the “Registration Rights Agreement”) is dated as of February 25, 2010, and is entered into by and between MAKO Surgical Corp., a Delaware corporation having its principal office at 2555 Davie Road, Fort Lauderdale, Florida 33317 (the “Company”), and Z-Kat, Inc., a Florida corporation having its principal office at 5011
March 10, 2010	S-8	As filed with the United States Securities and Exchange Commission on March 10, 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT PURSUANT TO GENERAL INSTRUCTION E TO FORM S-8 PART II INFORMATION REQUIRED IN THE R As filed with the United States Securities and Exchange Commission on March 10, 2010 Registration No.
March 10, 2010	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 Commission file number: 001-33966 MAK UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 Commission file number: 001-33966 MAKO SURGICAL CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-1901148 (State or Other Jurisdiction of Incorporation or Organizat
March 8, 2010	EX-99.1	Three Months Ended December 31, EX-99.1 2 mako101083ex99-1.htm PRESS RELEASE DATED MARCH 8, 2010 Exhibit 99.1 MAKO Surgical Corp. Reports 2009 Fourth Quarter and Full Year Operating Results Highlights Fourth quarter revenue totaled $8.9 million Commercial installed base increased by seven systems to 36 RIO® systems 561 MAKOplasty® procedures performed, a 34% sequential increase from third quarter 2009 FORT LAUDERDALE, FL – (GLOB
March 8, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2010 MAKO Surgical Corp. ( mako1010838k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (Stat
February 23, 2010	EX-10.2	2010 Performance Bonus Plan for S. Nunes - SVP of Sales & Marketing (this “Plan”) Exhibit 10.2 2010 Performance Bonus Plan for S. Nunes - SVP of Sales & Marketing (this “Plan”) 1. Overview a. A bonus (in the form of cash) shall be payable based on achievement of certain annual sales metrics of installs and procedures as set forth in the Company’s 2010 SVP of S&M Metric Scorecard, which are based on the Company’s 2010 Metrics Scorecard. 2. Target Bonus a. Executive shall receive
February 23, 2010	EX-10.1	MAKO Surgical Corp. 2010 LEADERSHIP CASH BONUS PLAN Exhibit 10.1 MAKO Surgical Corp. 2010 LEADERSHIP CASH BONUS PLAN Purpose of the Plan: The MAKO Surgical Corp. 2010 Leadership Cash Bonus Plan is designed to attract, retain and motivate management-level employees by providing meaningful annual cash incentives. Capitalized terms set forth herein are defined in the “Definitions” section below. Participants under this Plan are not eligible for awards
February 23, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2010 MAKO Surgical Cor mako1008148k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (
February 23, 2010	EX-10.3	SECOND AMENDMENT TO AMENDED EMPLOYMENT AGREEMENT Exhibit 10.3 SECOND AMENDMENT TO AMENDED EMPLOYMENT AGREEMENT This Second Amendment (“Amendment”) to Amended Employment Agreement is made effective February 17, 2010, by and between Maurice R. Ferré, M.D. (“Executive”) and MAKO Surgical Corp. (“Company”). Recitals Whereas, Executive and Company entered into that certain Amended Employment Agreement, dated November 12, 2007 (the “Agreement”); Where
January 7, 2010	EX-99.1	MAKO Surgical Corp. Announces 2009 Fourth Quarter Selected Operating Results EX-99.1 2 mako100081ex99-1.htm PRESS RELEASE DATED JANUARY 7, 2010 Exhibit 99.1 MAKO Surgical Corp. Announces 2009 Fourth Quarter Selected Operating Results Highlights Commercial installed base increased by seven systems to 36 RIO® systems 561 MAKOplasty® procedures performed, a 34% increase from third quarter 2009 FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — January 7, 2010 — MAKO Surgical Corp. (NASD
January 7, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2010 MAKO Surgical Corp. mako1000818k.htm - Generated by SEC Publisher for SEC Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2010 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (St
November 4, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-339
November 3, 2009	EX-99.1	Three Months Ended September 30, Exhibit 99.1 to MAKO Surgical Corp. Form 8-K dated November 3, 2009 Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Third Quarter 2009 Highlights Third quarter revenue totaled $6.7 million Commercial installed base increased by six systems to 29 RIO® systems 418 MAKOplasty® procedures performed, a 17% increase from second quarter 2009 Capital sales force size doubled to 16 sales
November 3, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2009 MAKO Surgical Corp MAKO Surgical Corp. Form 8-K dated November 3, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2009 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or o
August 17, 2009	8-K	UNITED STATES MAKO Surgical Corp. Form 8-K dated August 14, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2009 MAKO SURGICAL CORP. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or o
August 17, 2009	EX-1.1	7,000,000 Shares1 MAKO Surgical Corp. Common Stock PURCHASE AGREEMENT EX-1.1 2 mako093682ex1-1.htm PURCHASE AGREEMENT DATED AUGUST 14, 2009 Exhibit 1.1 [Execution Version] 7,000,000 Shares1 MAKO Surgical Corp. Common Stock PURCHASE AGREEMENT August 14, 2009 PIPER JAFFRAY & CO. As Representative of the several Underwriters named in Schedule I hereto c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: MAKO Surgical Corp., a Del
August 14, 2009	FWP	MAKO Surgical Corp. 7,000,000 Shares Filed Pursuant To Rule 433 Issuer Free Writing Prospectus dated August 14, 2009 Relating to Registration Statements on Form S-3 Registration Nos.
August 14, 2009	424B5	Per Share 424B5 1 mako093531s1424b5.htm FORM 424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-159302 Registration No. 333-161343 PROSPECTUS SUPPLEMENT To Prospectus dated May 26, 2009 7,000,000 Shares MAKO SURGICAL CORP. Common Stock $7.25 per share • MAKO Surgical Corp. is offering 7,000,000 shares. • Trading symbol: NASDAQ Global Market – MAKO • The last reported sale price of our common stock
August 13, 2009	S-3MEF	As filed with the Securities and Exchange Commission on August 14, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant a MAKO Surgical Corp. FORM S-3 Registration No. 333- As filed with the Securities and Exchange Commission on August 14, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organiz
August 5, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 MA
August 4, 2009	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2009 MAKO Surgical Corp.
August 4, 2009	EX-99.1	Three Months Ended June 30, Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the Second Quarter 2009 Highlights Second quarter revenue totaled $14.9 million All RIO® system upgrades completed, associated deferred revenue recognized Commercial installed base increased to 23 RIO systems RIO system enables RESTORIS® MCK uni and bicompartmental knee procedures MAKOplasty® procedure volume up 35% from first quarter
June 5, 2009	424B3	12,980,951 Shares MAKO Surgical Corp. Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-155471 PROSPECTUS 12,980,951 Shares MAKO Surgical Corp. Common Stock This prospectus relates to the resale of up to 12,980,951 shares of our common stock that may be sold by the selling stockholders identified in this prospectus or a prospectus supplement. The shares covered by this prospectus consist of 4,916,434 shares issued upon the convers
May 28, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2009 MAKO Surgical Corp. (E MAKO SURGICAL CORP. FORM 8-K DATED MAY 27, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2009 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 001-33966 20-1901148 (State or other jur
May 18, 2009	EX-4.3	MAKO SURGICAL CORP. Exhibit 4.3 MAKO SURGICAL CORP. TO Trustee FORM OF INDENTURE Dated as of , Debt Securities MAKO SURGICAL CORP. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of , ss.310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608, 610 (c) Not Applicable ss.311(a) 613 (b) 613 ss.312(a) 701, 702(a) (b) 702(b) (c) 702(c) ss.313(a) 703(a) (b)
May 18, 2009	EX-12	MAKO SURGICAL CORP. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDEND AND ACCRETION REQUIREMENTS The Company Predecessor (1) (in thousands ) Earnings (loss): Three Months En Exhibit 12 MAKO SURGICAL CORP. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDEND AND ACCRETION REQUIREMENTS The Company Predecessor (1) (in thousands ) Earnings (loss): Three Months Ended March 31, Years Ended December 31, Nov. 12, 2004 through Dec. 31, Jan. 1, 2004 through Nov. 11, 2009 2008 2007 2006 2005 2004 2004 Pret
May 18, 2009	S-3	As filed with the Securities and Exchange Commission on May 18, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registran Registration No. 333- As filed with the Securities and Exchange Commission on May 18, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MAKO Surgical Corp. (Exact name of registrant as specified in its charter) Delaware 20-1901148 (State or other jurisdiction of (I.R.S. Employer incorporation or organizatio
May 7, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33966 M
May 6, 2009	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2009 MAKO Surgical Corp.
May 6, 2009	EX-99.1	Three Months Ended March 31, Exhibit 99.1 MAKO Surgical Corp. Reports Operating Results for the First Quarter 2009 FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — May 6, 2009—MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets both its robotic arm interactive orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced its
April 30, 2009	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14
April 28, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2009 MAKO Surgical Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2009 MAKO Surgical Corp.
April 28, 2009	EX-24.3_284107	EX-24.3_284107 Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Menashe R.
April 28, 2009	EX-10	EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of April 27, 2009 (the “Effective Date”), by and between Ivan Delevic (“Employee”) and MAKO Surgical Corp. (“Company”). 1. Employment On the terms and conditions set forth in this Agreement, the Company hereby employs the Employee as its Senior Vice President of Strategic Marketing & Business Development
April 28, 2009	EX-99	MAKO Surgical Corp. Appoints Senior Vice President of Strategic Marketing and Business Development Exhibit 99.1 MAKO Surgical Corp. Appoints Senior Vice President of Strategic Marketing and Business Development FORT LAUDERDALE, Fla., April 28, 2009 (GLOBE NEWSWIRE) - MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its robotic arm interactive orthopedic surgical platform and proprietary RESTORIS(r) implants for minimally invasive orthopedic knee procedures known as
March 12, 2009	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 Commission file number: 001-33966 MAKO Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 Commission file number: 001-33966 MAKO SURGICAL CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-1901148 (State or Other Jurisdiction of Incorpora
March 12, 2009	POS AM	As filed with the Securities and Exchange Commission on March 12, 2009 As filed with the Securities and Exchange Commission on March 12, 2009 Registration No.
March 12, 2009	S-8	As filed with the United States Securities and Exchange Commission on March 12, 2009 As filed with the United States Securities and Exchange Commission on March 12, 2009 Registration No.
March 12, 2009	S-8	As filed with the United States Securities and Exchange Commission on March 12, 2009 As filed with the United States Securities and Exchange Commission on March 12, 2009 Registration No.
March 10, 2009	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2009 MAKO Surgical Corp.
March 10, 2009	EX-99.1	Three Months Ended December 31, EX-99.1 2 mako091103ex99-1.htm PRESS RELEASE DATED MARCH 10, 2009 Exhibit 99.1 MAKO Surgical Corp. Reports 2008 Fourth Quarter and Full Year Operating Results FORT LAUDERDALE, FL – (GLOBENEWSWIRE) — March 10, 2009—MAKO Surgical Corp. (NASDAQ:MAKO), a medical device company that markets both its robotic arm interactive orthopedic surgical platform and proprietary RESTORIS® implants for minimally in
March 2, 2009	EX-99.1	FORM 3 JOINT FILER INFORMATION EX-99.1 2 ex-99d1.htm EX-99.1 Exhibit 99.1 FORM 3 JOINT FILER INFORMATION Name of “Reporting Persons”: Skyline Venture Partners V, L.P. (“SVP V”) Skyline Venture Management V, LLC (“SVM V”) John G. Freund (“Freund”) Address: c/o Skyline Venture Partners 525 University Avenue Palo Alto, California 94301 Designated Filer: Skyline Venture Partners V, L.P. Issuer and Ticker Symbol: MAKO Surgical, Corp
February 27, 2009	SC 13G	SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) MAKO Surgical Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 560879108 (CUSIP Number) December 31, 2008 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh
February 26, 2009	SC 13D	SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
February 26, 2009	SC 13D	SECURITIES AND EXCHANGE COMMISSION SC 13D 1 a09-62582sc13d.htm SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MAKO SURGICAL CORP. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 560879108 (CUSIP Number) Kerry Kenny 525 University Ave. Palo Alto, CA 94301 650-475-0144 (Name, Address and Telephone Number o
February 20, 2009	EX-10.2	EX-10.2 EXHIBIT 10.2 FRITZ L. LAPORTE AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this "Agreement") is made effective as of February 13, 2009 (the "Effective Date"), by and between MAKO Surgical Corp., a Delaware corporation (the "Company"), and Fritz L. LaPorte (the "Executive"). WHEREAS, Executive is and has been employed by Company and is currently the Comp

MAKO / Mako Surgical Corp. - Documents déposés auprès de la SEC, rapport annuel, procuration

Statistiques de base

SEC Filings

SEC Filings (Chronological Order)